Cargando…
Antimony Toxicity
Antimony toxicity occurs either due to occupational exposure or during therapy. Occupational exposure may cause respiratory irritation, pneumoconiosis, antimony spots on the skin and gastrointestinal symptoms. In addition antimony trioxide is possibly carcinogenic to humans. Improvements in working...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037053/ https://www.ncbi.nlm.nih.gov/pubmed/21318007 http://dx.doi.org/10.3390/ijerph7124267 |
_version_ | 1782197943691902976 |
---|---|
author | Sundar, Shyam Chakravarty, Jaya |
author_facet | Sundar, Shyam Chakravarty, Jaya |
author_sort | Sundar, Shyam |
collection | PubMed |
description | Antimony toxicity occurs either due to occupational exposure or during therapy. Occupational exposure may cause respiratory irritation, pneumoconiosis, antimony spots on the skin and gastrointestinal symptoms. In addition antimony trioxide is possibly carcinogenic to humans. Improvements in working conditions have remarkably decreased the incidence of antimony toxicity in the workplace. As a therapeutic, antimony has been mostly used for the treatment of leishmaniasis and schistosomiasis. The major toxic side-effects of antimonials as a result of therapy are cardiotoxicity (~9% of patients) and pancreatitis, which is seen commonly in HIV and visceral leishmaniasis co-infections. Quality control of each batch of drugs produced and regular monitoring for toxicity is required when antimonials are used therapeutically. |
format | Text |
id | pubmed-3037053 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Molecular Diversity Preservation International (MDPI) |
record_format | MEDLINE/PubMed |
spelling | pubmed-30370532011-02-11 Antimony Toxicity Sundar, Shyam Chakravarty, Jaya Int J Environ Res Public Health Review Antimony toxicity occurs either due to occupational exposure or during therapy. Occupational exposure may cause respiratory irritation, pneumoconiosis, antimony spots on the skin and gastrointestinal symptoms. In addition antimony trioxide is possibly carcinogenic to humans. Improvements in working conditions have remarkably decreased the incidence of antimony toxicity in the workplace. As a therapeutic, antimony has been mostly used for the treatment of leishmaniasis and schistosomiasis. The major toxic side-effects of antimonials as a result of therapy are cardiotoxicity (~9% of patients) and pancreatitis, which is seen commonly in HIV and visceral leishmaniasis co-infections. Quality control of each batch of drugs produced and regular monitoring for toxicity is required when antimonials are used therapeutically. Molecular Diversity Preservation International (MDPI) 2010-12 2010-12-20 /pmc/articles/PMC3037053/ /pubmed/21318007 http://dx.doi.org/10.3390/ijerph7124267 Text en © 2010 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0 This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Review Sundar, Shyam Chakravarty, Jaya Antimony Toxicity |
title | Antimony Toxicity |
title_full | Antimony Toxicity |
title_fullStr | Antimony Toxicity |
title_full_unstemmed | Antimony Toxicity |
title_short | Antimony Toxicity |
title_sort | antimony toxicity |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037053/ https://www.ncbi.nlm.nih.gov/pubmed/21318007 http://dx.doi.org/10.3390/ijerph7124267 |
work_keys_str_mv | AT sundarshyam antimonytoxicity AT chakravartyjaya antimonytoxicity |